Perceptive Advisors – CYTOMX THERAPEUTICS INC

Perceptive Advisors ownership history of CYTOMX THERAPEUTICS INC
QuarterValueSharesWeighting
Q1 2021$33,300
97.3%
4,307,948
67.2%
0.21%
16.0%
Q4 2020$16,880
-1.5%
2,577,0430.0%0.18%
-27.6%
Q3 2020$17,137
-20.2%
2,577,0430.0%0.25%
-28.2%
Q2 2020$21,467
-14.0%
2,577,043
-20.8%
0.35%
-46.5%
Q1 2020$24,958
-7.7%
3,253,9230.0%0.65%
21.0%
Q4 2019$27,040
12.6%
3,253,9230.0%0.54%
-17.0%
Q3 2019$24,014
-32.1%
3,253,923
3.2%
0.65%
-20.3%
Q2 2019$35,387
3.7%
3,153,923
-0.6%
0.81%
-15.7%
Q1 2019$34,120
-21.7%
3,173,923
9.0%
0.96%
-42.0%
Q4 2018$43,588
-11.5%
2,911,715
9.4%
1.66%
26.0%
Q3 2018$49,242
12.1%
2,661,715
38.5%
1.32%
14.3%
Q2 2018$43,930
-30.1%
1,921,715
-13.0%
1.15%
-34.5%
Q1 2018$62,841
19.5%
2,208,812
-11.3%
1.76%
1.0%
Q4 2017$52,571
4.0%
2,490,381
-10.4%
1.74%
80.6%
Q3 2017$50,526
134.5%
2,780,762
100.0%
0.96%
-11.0%
Q2 2017$21,550
-18.5%
1,390,381
-9.2%
1.08%
-28.0%
Q1 2017$26,434
160.4%
1,530,659
65.7%
1.51%
108.6%
Q4 2016$10,152
33.9%
923,763
24.5%
0.72%
37.5%
Q2 2016$7,579
-20.8%
742,0210.0%0.52%
-37.5%
Q1 2016$9,572
-28.6%
742,021
15.6%
0.84%
-15.2%
Q4 2015$13,399642,0470.99%